- Home
- About
- Team
- Today's Market
- Premium
- Research it
- Outlook
- Portfolio
- Mobile
- Trust Equitymaster
- Help
- Free Reports
MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Stock Quote
- CAPLIN POINT
CAPLIN POINT Share Price 
(CPNT)
Here is the latest stock price and chart of CAPLIN POINT. For a sector overview, read our pharmaceuticals sector report.
| Live BSE Quotes | Sep 24, 2018 (Close) | ||
|---|---|---|---|
| Price (Rs)434.85 | Open (Rs) 444.80 | High (Rs) 456.20 | Low (Rs) 425.20 |
| % Change-5.88 | Volume 3,989 | Value (Rs) 1,745,747 | 52-Week H/L 727.65 / 336.40 |
| Live NSE Quotes |
|---|
| Not listed |
| BSE Sensex | CNX Nifty |
- Charts
-
PERIOD - Advanced Charts new
- Charts by TradingView
CAPLIN POINT Share Price Today:
CAPLIN POINT last traded price had tanked 5.9% to Rs 434.9 on the BSE. The total volume of shares traded was 0.0 m.
Overall, the broader S&P BSE HEALTHCARE Index was down by 2.7%. And the benchmark S&P BSE SENSEX was at 36,305.0 (down 1.5%).
Over the last 30 days, the CAPLIN POINT share price is up 6.9%. And over the last one year, CAPLIN POINT share price is down 33.3%.
|
| |
Today's Market
Indian Indices Continue Sell-Off; Sensex Slumps Over 530 Points(Closing)
Share markets in India continued their sell-off seen during the last week and ended the day deep in the red. All sectoral indices traded on a negative note.
Related Views On News
The BSE HEALTHCARE Index Down 2% ; CAPLIN POINT Among Top Losers (Market Updates)
Sep 24, 2018 | Updated on Sep 24, 2018The BSE HEALTHCARE Index Down at 15,697 (down 2.1%). Among the top losers in the BSE HEALTHCARE Index today are CAPLIN POINT, VIMTA LABS and PIRAMAL ENTERPRISES. Meanwhile, the BSE Sensex has plunged 1.2% to 36,946.
GRANULES INDIA Plunges by 5%; BSE HEALTHCARE Index Down 1.6% (Market Updates)
Sep 24, 2018 | Updated on Sep 24, 2018GRANULES INDIA share price has plunged by 5% and its current market price is Rs 109. The BSE HEALTHCARE is down by 1.6%. The top gainers in the BSE HEALTHCARE Index are THYROCARE TECHNOLOGIES (up 2.5%) and BLISS GVS PHARMA (up 0.9%). The top losers are GRANULES INDIA (down 5.1%) and PIRAMAL ENTERPRISES (down 5.1%).
Aster DM Healthcare (IPO)
Feb 10, 2018Should you subscribe to the IPO of Aster DM Healthcare Ltd?
Shalby Ltd. (IPO)
Dec 2, 2017Should you subscribe to the IPO of Shalby Ltd?
The Power of 5 Minutes (The 5 Minute Wrapup)
Jun 16, 2017Here's what you can expect from The 5 Minute Wrapup in the coming months and years.
More Views on NewsMost Popular
My First Pharma Stock Recommendation!(The 5 Minute Wrapup)
Sep 21, 2018This company has not only created a niche in the pharma space, it has done so profitably.
Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)
Sep 12, 2018Richa has discovered the single most profitable opportunity in the market - read on to discover more...
Are You Blindly Investing In Equities? Read This...(Outside View)
Sep 11, 2018PersonalFN explains how blindly investing in equities can prove hazardous to your wealth and health.
Investors Are Redeeming From Equity Mutual Funds Now. Should You?(Outside View)
Sep 12, 2018PersonalFN elucidates if you should redeem from equity mutual fund now, and the approach to follow before you decide to sell mutual funds.
Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)
Sep 14, 2018Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.
MoreTRACK CAPLIN POINT
- Track your investment in CAPLIN POINT with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
- Add To MyStocks
OTHER USEFUL LINKS
MARKET STATS
|
| |
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
APPS
FOLLOW
Copyright © Equitymaster Agora Research Private Limited.
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.